Drug Shortage Report for APO-RISPERIDONE

Last updated on 2017-06-01 History
Report ID 3183
Drug Identification Number 02282119
Brand name APO-RISPERIDONE
Common or Proper name RISPERIDONE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) RISPERIDONE
Strength(s) 0.25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-04-20
Actual start date 2017-04-14
Estimated end date 2017-06-02
Actual end date 2017-05-31
Shortage status Resolved
Updated date 2017-06-01
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-06-01 French Compare
v13 2017-06-01 English Compare
v12 2017-05-30 French Compare
v11 2017-05-30 English Compare
v10 2017-05-10 French Compare
v9 2017-05-10 English Compare
v8 2017-05-10 French Compare
v7 2017-05-10 English Compare
v6 2017-04-17 French Compare
v5 2017-04-17 English Compare
v4 2017-04-07 French Compare
v3 2017-04-07 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare